What This Means Practically When Hers or any telehealth platform offers compounded GLP-1 options, these are not Ozempic, Wegovy, Mounjaro, or Zepbound
FDA has also approved dapagliflozin for treatment for CKD (2021) [26] and has given priority review for empagliflozin to potentially treat heart failure not associated with left ventricular ejection fraction [27]
H.KoharaM.Tsukiyama-KoharaK
[13] These findings are further reinforced by pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS) database (n=48,214 reports), where GLP-1RA-related gastrointestinal adverse events, including nausea (9651 vs 38,030) and vomiting (4383 vs 17,062), were lower with combination therapy compared to GLP-1RA monotherapy, suggesting improved tolerability when metformin is added
and my blood pressure and cholesterol have almost returned to normal